460 — Sihuan Pharmaceutical Holdings Share Price
0.000.00%
Last trade - 00:00- HK$4.76bn
- HK$2.07bn
- CNY1.86bn
- 12
- 57
- 31
- 20
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | 9.51% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.99 | ||
| Price to Tang. Book | 1.2 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.36 | ||
| EV to EBITDA | 19.05 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.18% | ||
| Return on Equity | -1.18% | ||
| Operating Margin | 8.69% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 2,878.32 | 2,464.23 | 3,038.39 | 2,181.19 | 1,860.54 | 2,150 | 2,514 | -8.6% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +15.49 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sihuan Pharmaceutical Holdings Group Ltd is a holding company mainly engaged in pharmaceutical manufacturing business. The Company operates three segments. Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. Innovative Medicine and Other Medicine segment is engaged in the research and development of innovative drugs in the fields of digestion, oncology, non-alcoholic hepatitis, diabetes and complications. The Company also operates Generic Medicine segment.
Directors
- Fengsheng Che CHM (59)
- Weicheng Guo CEO (57)
- Yiau Chong Choi CFO (47)
- Jionglong Zhang CIN (59)
- Yanling Chen EDR (43)
- Ming Wai Mok SEC
- Patrick Sun NID (62)
- Wah Kwong Tsang NID (68)
- Xun Zhu NID (63)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 26th, 2006
- Public Since
- October 28th, 2010
- No. of Employees
- 2,872
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 9,329,999,000
- Address
- 21/F, Building 2,Zhbng 2000 Bsns Ctr, BEIJING, 100025
- Web
- http://www.sihuanpharm.com/
- Phone
- +86 75588609726
- Auditors
- Ernst & Young
Upcoming Events for 460
Similar to 460
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Sihuan Pharmaceutical Holdings share price?
As of Today at 19:19 UTC, shares in Sihuan Pharmaceutical Holdings are trading at HK$0.51. This share price information is delayed by 15 minutes.
How has the Sihuan Pharmaceutical Holdings share price performed this year?
Shares in Sihuan Pharmaceutical Holdings last closed at HK$0.51 and the price had moved by -37.8% over the past 365 days. In terms of relative price strength the Sihuan Pharmaceutical Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -35.08% over the past year.
What are the analyst and broker recommendations for Sihuan Pharmaceutical Holdings?
The overall consensus recommendation for Sihuan Pharmaceutical Holdings is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Sihuan Pharmaceutical Holdings dividend yield?
Sihuan Pharmaceutical Holdings does not currently pay a dividend.
Does Sihuan Pharmaceutical Holdings pay a dividend?
Sihuan Pharmaceutical Holdings does not currently pay a dividend.
When does Sihuan Pharmaceutical Holdings next pay dividends?
Sihuan Pharmaceutical Holdings does not currently pay a dividend.
How do I buy Sihuan Pharmaceutical Holdings shares?
To buy shares in Sihuan Pharmaceutical Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sihuan Pharmaceutical Holdings?
As of the previous close price of HK$0.51, shares in Sihuan Pharmaceutical Holdings had a market capitalisation of HK$4.76bn.
Where are Sihuan Pharmaceutical Holdings shares listed?
Here are the trading details for Sihuan Pharmaceutical Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 460
What kind of share is Sihuan Pharmaceutical Holdings?
Based on an overall assessment of its quality, value and momentum Sihuan Pharmaceutical Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sihuan Pharmaceutical Holdings share price forecast for 2024?
The analyst consensus target price for shares in Sihuan Pharmaceutical Holdings is HK$2.68. That is 426.11% above the last closing price of HK$0.51.
Analysts covering Sihuan Pharmaceutical Holdings currently have a consensus Earnings Per Share (EPS) forecast of -CNY0.02 for the next financial year.
What is the trend in the Sihuan Pharmaceutical Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sihuan Pharmaceutical Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -23.35%.
As of the last closing price of HK$0.51, shares in Sihuan Pharmaceutical Holdings were trading -19.52% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sihuan Pharmaceutical Holdings PE Ratio?
The Sihuan Pharmaceutical Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.51.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sihuan Pharmaceutical Holdings?
Sihuan Pharmaceutical Holdings' management team is headed by:
- Fengsheng Che - CHM
- Weicheng Guo - CEO
- Yiau Chong Choi - CFO
- Jionglong Zhang - CIN
- Yanling Chen - EDR
- Ming Wai Mok - SEC
- Patrick Sun - NID
- Wah Kwong Tsang - NID
- Xun Zhu - NID